Personalized Anticoagulant Therapy for Pulmonary Thromboembolism

Inclusion Criteria

• •1. Age ≥ 18 years old;
• •2. Adult patients with objectively diagnosed pulmonary thromboembolism (PTE) (with or without concomitant deep vein thrombosis);
• •3. Specific populations meeting any of the following criteria: elderly patients (≥75 years old); patients with impaired kidney function (creatinine clearance estimated by the Cockcroft-Gault formula, CrCl \< 60ml/min); patients with active malignancies (under treatment or with unrecovered malignancies);
• •4. Patients who have not started anticoagulant therapy before enrollment and are planned for anticoagulant treatment after evaluation by the attending physician;
• •5. Ecpected life expectancy longer than 3 months.
• •6. Patients who understand and agree to participate in this study, sign the informed consent form, and adhere to regular follow-up visits.